Skip to main content

Table 3 Hemolysis of 6.5 × 107(2.6 x107 /ml) SRBC by celecoxib (80 μM) and tamoxifen (20 and 40 μM). The SRBC (2.5 ml) were incubated in a shaking bath for 19 h at 37°C. The cells were centrifuged and the supernates analyzed for oxyhaemoglobin by absorption at 413 nm. Complete hemolysis was calculated from the absorption of the H2O lysate of the centrifuged cells of the controls. Controls for absorption at 413 nm of the reagents in the PBS/BSA vehicle as well as controls that contained known amounts of SRBC lysate were used to measure the effects of NSAIDs, if any, on oxyhemoglobin absorption.

From: Cyclooxygenase expression is not required for release of arachidonic acid from cells by some nonsteroidal anti-inflammatory drugs and cancer preventive agents

Reagent

Hemolysis * %

Absorbance 413 nm

H2O

100

2.442

  

2.439

  

2.423

  

2.427

  

m = 2.433 ± 0.01

Celecoxib (80 μM)

29

0.799

  

0.912

  

0.988

  

0.635

  

m = 0.834 ± 0.077

Tamoxifen (40 μM)

96

2.293

  

2.349

  

2.396

  

2.352

  

m = 2.348 ± 0.02

Tamoxifen (20 μM)

29

0.789

  

0.844

  

1.044

  

0.701

  

m = 0.845 ± 0.07

PBS/BSA (Control)

0

0.193

  

0.214

  

0.186

  

0.134

  

m = 0.182 ± 0.017

  1. * = % Hemolysis of 6.5 × 107 SRBC (2.6 × 107 SRBC/ml).